Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 57 of 57
Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis
NCT00027443
Correlation of Endothelial Function and Early Coronary Artery Disease in Humans
NCT00271492
Using Networks, Informatics, Technology, and Education in Care for People With Diabetes
NCT00421850
Attenuation Corrected Cardiac SPECT Using the GE Hawkeye Camera System
NCT00587730
Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
NCT00587444
Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women
NCT00626119
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
NCT00275535
Risk Factors for Venous Thromboembolism in the Community
NCT00011180
Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection
NCT00014651
Comparison of A Mobile-Bearing Total Knee System With A Fixed-Bearing Total Knee System In Cemented Total Knee Arthroplasty
NCT00589108
Siblings With Ischemic Stroke Study
NCT00108940
Radiofrequency Ablation in Relieving Pain in Patients With Bones Metastases
NCT00029029
Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
NCT00006219
Unprepped CT Colonography
NCT00586053
Contact Allergies to Dental Metal as a Possible Risk Factor for Oral Cancer
NCT00693550
Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy
NCT00684905
Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00005068
Alpha Lipoic Acid for Burning Mouth
NCT00387543
Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
NCT00004482
PS-341 in Treating Patients With Advanced Cancer
NCT00006362
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
NCT00004260
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
NCT00004075
Dolastatin 10 in Treating Patients With Advanced Kidney Cancer
NCT00003914
Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)
NCT00004551
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
NCT00003690
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
NCT00588120
Angiotensin-II Blockade in Mitral Regurgitation
NCT00587470
DHEA and Testosterone Replacement in Elderly
NCT00254371
Pharmacologic Relapse Prevention for Alcoholic Smokers
NCT00000457
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
NCT00003038
Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
NCT00003049
Genetic Epidemiology of Responses to Antihypertensives
NCT00005520
Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
NCT00002693
Effect of Exercise Intervention on Various Physiologic Factors That Change With Increasing Age
NCT00283673
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
NCT03941184
Photodynamic Therapy (PDT) in Lung Cancer
NCT00984243
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
NCT00002630
Uric Acid Levels and Endothelial Functions
NCT02862522
Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas
NCT00002876
Combination Chemotherapy in Treating Patients With Sarcoma
NCT00662233
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors
NCT00002472
Intraperitoneal Versus Extraperitoneal Colostomy
NCT00964379
Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
NCT00443716
To Evaluate Success of Cement Treatment of Spinal Compression Fractures
NCT00166374
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.